Skip to content

Prospective Multicenter Validation of a Severity Score of Strangulated Small Bowel Occlusion

Prospective Multicenter Validation of a Clinicoradiological Score for Predicting the Severity of Strangulated Small Bowel Occlusion

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01125280
Enrollment
300
Registered
2010-05-18
Start date
2010-07-31
Completion date
2013-07-31
Last updated
2010-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal Obstruction

Keywords

Small bowel occlusion, Conservative treatment for small bowel occlusion, Surgical treatment for small bowel occlusion, Small bowel resection, Score of severity of small bowel occlusion

Brief summary

The purpose of this study is to apply and validate a clinicoradiological score for the prediction of severity of strangulated small bowel occlusion (SBO). This score was elaborated by analyzing clinical, biological and radiological parameters of patients admitted in an emergency center for acute strangulated SBO. Two clinical, two biological and two radiological parameters were shown to significantly predict the surgical outcome of SBO patients. Since any delay in the management of SBO may result in devastating consequences, a score predicting the severity of the SBO episode is an essential tool for helping in the management of SBO patients. A prospective multicenter validation of the score is mandatory for its extended use.

Detailed description

Elaboration of the SBO score: Intestinal ischaemia as a result of small bowel obstruction (SBO) requires prompt recognition and early intervention. A clinicoradiological score was sought to predict the risk of ischaemia in patients with SBO. A determined protocol for the assessment of patients presenting with SBO was used. A logistic regression model was applied to identify determinant variables and construct a clinical score that would predict ischaemia requiring resection. Of 233 successive patients with SBO, 138 required laparotomy of whom 45 underwent intestinal resection. In multivariable analysis, six variables correlated with small bowel resection and were given one point each towards the clinical score: history of pain lasting more than 4 days, guarding, C-reactive protein level at least 75 mg/l, leucocyte count over 10 G/l, free intraperitoneal fluid volume exceeding 500 ml on computed tomography (CT) and reduction of CT small bowel wall contrast enhancement. The risk of intestinal ischaemia was 6 per cent in patients with a score of 1 or less, whereas 21 of 29 patients with a score of three or more 3 underwent small bowel resection. A positive score of 3 or more had a sensitivity of 67.7 per cent and specificity 90.8 per cent; the area under the receiver operating characteristics curve was 0.87 (95 per cent confidence interval 0.79 to 0.95). By combining clinical, laboratory and radiological parameters, the clinical score allowed early identification of strangulated SBO. The purpose of the present protocol is to apply the SBO score as a prospective multicenter study. After informed consent, SBO patients corresponding to the inclusion and exclusion criteria will be managed according to the score. Patients with a score of 0 to 2 will be treated conservatively, while a score ≥3 will imply emergency surgery. For its validation, the conservative and surgical outcomes will be compared with the results obtained for the elaboration of the score.

Interventions

PROCEDUREConservative treatment versus surgical treatment

Conservative treatment: starving, nasogastric tube Surgical treatment: open laparotomy, adhesiolysis, with or without small bowel resection

Sponsors

Centre Hospitalier Universitaire Vaudois
CollaboratorOTHER
University Hospital, Geneva
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Strangulated small bowel occlusion * Diagnosis confirmation by CT-scan with iv contrast * Blood analysis comprising: leucocyte count and repartition, CRP, lactates

Exclusion criteria

* Large bowel occlusion * Strangulated hernia * Tumor occlusion * Post-Radiotherapy occlusion * Paralytic ileus (neurological diseases, diabetes, etc) * Inflammatory bowel diseases * Any condition able to modify the clinical or biological parameters without any relation with the SBO episode (inflammatory, infectious diseases, etc)

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients with a score of 0-2 with successful conservative treatment3 daysAccording to the score, patients will be managed either conservatively or surgically. Patients with a score of 0-2 will be treated conservatively. The success of the decision and the treatment will be evaluated after 3 days since admission. Indeed, patients with conservative treatment who do not retrieve a gastrointestinal transit after 3 days will be operated on.

Secondary

MeasureTime frameDescription
Proportion of patients with a score ≥3 needing small bowel resection1 dayPatients with a score ≥3 will be emergently operated on with a surgical delay below 12 hours since admission. During surgery, segmental small bowel resection will be performed in case of ischemia or necrosis. The need of small bowel resection will be related to the pre-operative score.

Countries

Switzerland

Contacts

Primary ContactFrank P Schwenter, MD, PhD
frank.schwenter@hcuge.ch+41223727703
Backup ContactPhilippe Morel, MD
philippe.morel@hcuge.ch+41223727702

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026